posted
FONR today traded at $21.44 and closed at $21.18. It might trade at $22.00-22.50 this week. The resistance above $22 seems to be significant. I'm concerned on how fast it went from $13 to $22.50, dropped to low $19's and now back at today's close above $21. The volume has been high the last month. If volume get down below 30,000 shares, I don't expect FONR to stay at the current level above $20, then I expect FONR to trade between $ 17-18 before earnings are out September 9-13. If Q4 EPS is above last year FONR trade above $25. But if Q4 EPS is below Q4 2015 FONR might drop to $14-15. We saw it in in 2014. FONR dropped from $28 to $17 within few days.
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
fonar closed at 22.50 t0day still can't put my finger on any one thing for its moves.
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
GRT (Earnings Growth Rate): GRT reflects a company's one to three year forecasted earnings growth rate in percent per year. FONR has a forecasted Earnings Growth Rate of 13.00 %, which VectorVest considers to be good.
EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. FONR has a forecasted EPS of $2.39 per share. VectorVest determines this forecast from a combination of recent earnings performance and traditional fiscal and/or calendar year earnings forecasts.
P/E (Price to Earnings Ratio): P/E shows the dollars required to buy one dollar of earnings. FONR has a P/E of 9.81. The average P/E of all the stocks in the VectorVest database is 39.23.
EY (Earnings Yield): EY reflects earnings per share as a percent of Price. FONR has an EY of 10.20 %. This is above the current average of 2.55 % for all the stocks in the VectorVest database.
GPE (Growth to P/E Ratio): FONR has a GPE rating of 1.33. A stock is commonly considered to be undervalued when GPE is greater than 1.00. This does not take into account the effect of interest rates on P/E ratios. With long-term interest rates currently at 2.53 %, the operative GPE ratio is 0.06. Therefore, FONR may be considered to be undervalued.
DIV (Dividend): VectorVest reports annual, regular, cash dividends as indicated by the most recent payments. Special distributions, one-time payments, stock dividends, etc., are not generally included in DIV. FONR does not pay a dividend.
DY (Dividend Yield): DY reflects dividend per share as a percent of Price. FONR does not pay a dividend, so it does not have a Dividend Yield rating. DY equals 100 x (DIV/Price). It is useful to compare DY with EY. If DY is not significantly lower than EY, the dividend payment may be in jeopardy.
DS (Dividend Safety): DS is an indicator of the assurance that regular cash dividends will be declared and paid at current or at higher rates for the foreseeable future. FONR does not pay a dividend, so it does not have a Dividend Safety rating. Stocks with DS values above 75 typically have RS values well above 1.00 and EY levels that are much higher than DY.
DG (Dividend Growth Rate): Dividend Growth is a forecasted annual growth rate of a company's dividend based on historical dividend payments and dividend predictability. It is a subtle yet important indicator of a company's financial performance. It also provides some insight into the board's outlook on the company's ability to increase earnings. FONR does not pay a dividend, so it does not have a Dividend Growth rating.
YSG (YSG-Vector): YSG is an indicator which combines DY, DS and DG into a single value, and allows direct comparison of all dividend-paying stocks in the database. FONR does not pay a dividend, so it does not have a YSG rating. Stocks with the highest YSG values have the best combinations of Dividend Yield, Safety and Growth. These are the stocks to buy for somewhat above current income and long-term growth.
AvgVol: AvgVol is the 50 day moving average of daily volume as computed by VectorVest. FONR has an AvgVol of 58,739 shares traded per day.
%Vol: %Vol reflects the percent change in today's trading volume as compared to the AvgVol. %Vol equals ((Volume - AvgVol) / AvgVol ) * 100. FONR had a %Vol of -6.78 % on Monday, July 18, 2016
%PRC: FONR Price changed 1.65 % from the prior day's closing price.
Sales: FONR has annual sales of 71,000,000
Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. FONR has a Sales Growth of 9.00 % per year. This is good.
Sales Per Share (SPS): FONR has annual sales of $11.12 per share.
Price to Sales Ratio (P/S): FONR has a P/S of 2.11.
Shares: FONR has 6,000,000 shares of stock outstanding.
Market Capitalization: FONR has a Market Capitalization of 150,000,000.
Business Sector: FONR has been assigned to the Healthcare Business Sector. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.
Industry Group: FONR has been assigned to the Healthcare (Instruments) Industry Group. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.
Business Description: Fonar Corporation (Fonar), incorporated on July 17, 1978, operates in two segments: medical equipment segment, and physician management and diagnostic services segment. Fonar is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries.
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
-------------------- Wise men learn more from fools than fools from the wise. Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
Nov 9, 2016 2:00 PM 1 Comment MELVILLE, NY--(Marketwired - Nov 9, 2016) - FONAR Corporation ( NASDAQ : FONR ) Diluted Net Income per Common Share Available to Common Stockholders increased 26% to $0.54 per share for 1st Quarter Fiscal 2017 from $0.43 during the same quarter one year earlier. Net Income Available to Common Stockholders increased 25% to $3.3 million for 1st Quarter Fiscal 2017 versus the same quarter one year earlier. Net Income increased 30% to $4.5 million for 1st Quarter Fiscal 2017 versus the same quarter one year earlier. Income from Operations for 1st Quarter Fiscal 2017 increased 31% to $4.8 million versus the same quarter one year earlier. Total Revenues - Net for 1st Quarter Fiscal 2017 increased 6% to $18.7 million versus the same quarter one year earlier
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
few ideas that appear to be medical stocks a value investor could love.
Fonar (FONR) makes MRI machines and also has four diagnostic imaging facilities in Florida; it also manages 25 MRI scanning facilities, which includes 18 in New York and seven in Florida. According to Fonar's website, it is the oldest magnetic resonance imaging (MRI) company in the industry and its chairman, Dr. Raymond Damadian, is the inventor of the scanning device. Business is pretty good right now, and Fonar's most recent earnings report showed solid gains in revenues and profits. Best of all, the stock looks cheap here, with an EV/EBIT ratio of just 7.3. The F-score is a solid seven, so the company is in decent financial shape with solid prospects.
The thing that interested me about this company is its Upright Multi-Position MRI scanner. I have had a few MRIs over the years, and I can tell you I hate being in that tube. This new scanner allows patients to sit upright and watch TV or read a book while the scan is done. It also allows the scan to be done in full weight-bearing position, which can be very useful when examining the back or spine under the stresses they might experience during normal activities.
The company has some exciting products under development as well. The OR-360º is a room-size MRI that will allow surgeons, along with their assistants and equipment, to operate without obstruction inside the scanner's magnet using the imagery provided in real time as they work. Fonar also is working on technology for visualizing and quantifying the cerebral hydraulics of the central nervous system. Both of these developments could be growth drivers in the future.
As usual, I have run out of room to talk about the other medical companies that pass my basic value/private equity screens. This is all very much a work in progress, but health care is a source of potential 100-to-1 ideas, so finding a way to uncover those with huge potential at bargain prices is worth a little time and effort.
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
MELVILLE, N.Y., June 20, 2017 (GLOBE NEWSWIRE) -- FONAR Corporation (FONR), The Inventor of MR Scanning™, reported today that Health Management Company of America (HMCA), of which FONAR is the majority owner, has now purchased more than 99% interest in the FONAR MRI equipment lease related to Stand-Up MRI of Great Neck, thereby adding to FONAR’s net income and cash flow.
Turnkey Services of Great Neck, LLC, by way of an operating lease, has been the sole provider of a FONAR UPRIGHT® Multi-Position™ MRI to HMCA-managed Stand-Up MRI of Great Neck, which is located in Great Neck, New York.
Timothy R. Damadian, President and CEO of FONAR Corporation, said, “We are pleased to report that with this transaction and the other three acquisitions made within the last twelve months, we continue to contribute to the growth and financial stability of the company and eagerly continue our search for similar promising opportunities.”
About FONAR:
FONAR, The Inventor of MR Scanning™, located in Melville, NY, was incorporated in 1978 and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's signature product is the FONAR UPRIGHT® Multi-Position™ MRI (also known as the STAND-UP® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as in the conventional lie-down position. The FONAR UPRIGHT® MRI often detects patient problems that other MRI scanners cannot because they are lie-down and "weightless-only" scanners. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. Regarding patient comfort, as one FONAR customer stated, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while watching TV.
UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, Multi-Position™, Upright Radiology™, The Proof is in the Picture™, True Flow™, pMRI™, Spondylography™, Dynamic™, Spondylometry™, CSP™, and Landscape™, are trademarks of FONAR Corporation.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
MELVILLE, N.Y., June 23, 2017 (GLOBE NEWSWIRE) -- FONAR Corporation (FONR), The Inventor of MR Scanning™, reported today that it is set to join the broad-market Russell 3000® Index at the conclusion of the Russell indexes annual reconstitution, effective after the US market opens on June 26, according to a preliminary list of additions posted June 9 and today, June 23.
The annual Russell indexes reconstitution captures the 4,000 largest US stocks as of the end of May, ranking them by total market capitalization. Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as in appropriate growth and value style indexes. FTSE (Financial Times and Stock Exchange) Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
Raymond Damadian, founder and Chairman of FONAR said, “I am proud of this remarkable milestone for our Company. It is based on our Company’s share price and is an indication that we have been delivering shareholder value. It is a result of the successful strategy we have put in place in recent years that has allowed the Company to be profitable for 28 consecutive quarters.”
Timothy R. Damadian, President and CEO of FONAR said, “FONAR’s inclusion in the Russell 3000 is important because it gives institutions, mutual funds and the investing community greater visibility of our Company. They’re all looking for successful value stocks, and we’ve shown that FONAR can deliver.”
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $8.4 trillion in assets are benchmarked against Russell’s US indexes. Russell indexes are part of FTSE Russell, a leading global index provider. For more information on the Russell 3000® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.
About FTSE Russell:
FTSE Russell is a leading global index provider creating and managing a wide range of indexes, data and analytic solutions to meet client needs across asset classes, style and strategies. Covering 98% of the investable market, FTSE Russell indexes offer a true picture of global markets, combined with the specialist knowledge gained from developing local benchmarks around the world.
FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $12.5 trillion is currently benchmarked to FTSE Russell indexes. For over 30 years, leading asset owners, asset managers, ETF providers and investment banks have chosen FTSE Russell indexes to benchmark their investment performance and create investment funds, ETFs, structured products and index-based derivatives. FTSE Russell indexes also provide clients with tools for asset allocation, investment strategy analysis and risk management.
A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on index innovation and customer partnership applying the highest industry standards and embracing the IOSCO Principles. FTSE Russell is wholly owned by London Stock Exchange Group
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
posted
FONAR Celebrates Two Milestones: the 40th Birthday of the MRI Industry and the Impact of Joining the Russell 3000® Index
MELVILLE, N.Y., July 10, 2017 (GLOBE NEWSWIRE) -- FONAR Corporation (FONR), The Inventor of MR Scanning™, celebrates the 40th anniversary of the world’s first MRI picture, by FONAR’s founder, Raymond V. Damadian, M.D., and his team, on his human-size MRI machine, thereby birthing what has grown into a multi-billion-dollar industry. FONAR also celebrates the very positive impact of being included, as of June 26, in the Russell 3000® Indexes annual reconstitution, which has increased the Company’s membership in related index funds and ETFs (Exchange Traded Funds) to over 60, allowing mutual funds, institutions, and the investing community greater visibility of FONAR and helping to build shareholder value.
Raymond V. Damadian, M.D., chairman and founder of FONAR, together with his two post-graduate assistants, Lawrence Minkoff, Ph.D. and Michael Goldsmith, Ph.D., began construction of the first human-sized magnetic resonance imaging (MRI) scanner, in January of 1976, at their research lab in SUNY Downstate Medical Center, Brooklyn, NY. This first scanner, named Indomitable, is now at the Smithsonian Institution.
After many years of research, Dr. Damadian’s moment of truth began late on July 2, 1977 when his graduate student, Lawrence Minkoff, Ph.D., entered Indomitable. The whole-body scan of Dr. Minkoff’s chest was completed at 4:45 A.M. on July 3, 1977.
MR scanning was proposed for the first time in the paper "Tumor Detection by Nuclear Magnetic Resonance" (Science, March 19, 1971). That paper reported that there are dramatic differences in the characteristic NMR (MRI) parameters, known as T1 and T2, between healthy and cancerous tissues, as well as between the healthy tissues themselves. It is precisely these differences that provide the exceptional anatomic contrast (pixel contrast) of the medical images generated by today's MRI scanners.
In February 1974, U.S. Patent #3,789,832 (filed March 17, 1972), “Apparatus and Method for Detecting Cancer in Tissue,” was granted. It was the world's first description of an apparatus and method for scanning the human body by MRI. It was the first of 4,552 patents for MRI (as of 2/21/13) issued by the United States Patent Office. It introduced the T1 and T2 tissue relaxation differences reported in Science that provided the anatomic detail of the body's critical soft tissue VITAL organs (brain, kidney, heart, liver, muscle, intestine) that had been missing from medical images (x-ray images) for more than a century. These T1 and T2 tissue relaxation differences discovered by Dr. Damadian became the foundation of nearly all of the images produced by today's MRI scanners. The Company was successful with this patent in its litigation with General Electric that culminated in 1997 resulting in GE paying approximately $46.4 million for FONAR's cancer detection patent and an additional $82.3 million for its multi-angle oblique imaging patent.
Dr. Damadian said, “What I am most grateful for is that the MRI scanner is now found throughout the world, with over 20,000 installed world-wide and over 60 million MRI examinations being performed each year. I am sincerely grateful for the blessing that has enabled me to help so many people.”
Timothy R. Damadian, President and CEO of FONAR said, “I remember being at an Independence Day family gathering the day my father and his team had finally achieved what they had been so diligently working on – the first MRI picture. I was just 13 years old then. I remember my family and I being very happy and proud of him, but, frankly, I had no sense whatsoever of the importance of that event. Having said that, I’m not sure there were many people, if any, back then who recognized his achievement as a medical game-changer, aside from my father, that is. He went on to build FONAR and launched an industry that has helped countless numbers of people the world over. I remain proud of him and am grateful for the opportunity to be part of his adventure.”
Posts: 3827 | From: beautiful California | Registered: Sep 2008
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
